Veterinary Vaccines Market

Veterinary Vaccines Market Trends and Opportunity
Analysis
Veterinary vaccination enhances the health of animals, thus improving their life expectancies.
Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis
rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease
and influenza adversely affect livestock across the globe. Economic losses due to death of
livestock is significant as it impacts the supply of dairy products, meat, and other poultry
products. Veterinary biologics are governed by the U.S. Department of Agriculture (USDA)
Center for Veterinary Biologics. To combat increasing prevalence of potentially fatal veterinary
diseases, there’s a significant spike in demand for combination vaccines that allow for greater
accuracy and stability of the finished product. Regulations are also focusing on improving
stability, consistency and quality of vaccines produced. Maintaining the quality of production
will circumvent risk of side effects.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/125
As per the American Veterinary Medical Foundation, core vaccines such as rabies, feline viral
rhinotracheitis, feline panleukopenia, canine parvovirus infection, and canine hepatitis are
recommended for every pet, while non-core vaccines such as canine kennel cough and feline
leukemia are recommended based on specific needs of the animal. However, low awareness
among pet owners and livestock managers inhibits the growth of veterinary vaccines market,
especially in emerging economies.
The global veterinary vaccines market was valued at US$ 5,688.7 million in 2015 and is
expected to witness a moderate CAGR of 5.9% during the forecast period (2016 – 2024).
Increasing incidence of veterinary diseases to drive the growth of veterinary vaccines market
According to the 2015 Global Animal Disease Intelligence Report by the Food and Agriculture
Organization (FAO), prevalence of foot-and-mouth disease (FMD) was especially high in
Morocco, Saudi Arabia, Turkey, Northern, and Southern Africa. Ebola (Zoonotic disease)
continued to be prevalent in West Africa. Also, rabies that leads to thousands of human deaths
worldwide is prevalent in 150 countries according to the WHO, with highest number of related
deaths reported in Asia and Africa. Thus, these regions are amongst the largest target regions
for veterinary vaccines market. Incidence rate of rabies has reduce drastically in Latin America
and Caribbean regions due to successful implementation dog rabies control programs.
Market Dynamics
Rapid increase in population of companion animals and livestock animals globally is one of the
major factors expected to favor market growth for veterinary vaccines. Rise in awareness about
the vaccination programs are further favoring growth of the global veterinary vaccines market.
The market is estimated to witness considerable revenue traction over the forecast period, due
to increasing incidence of food-borne zoonotic diseases worldwide. Also, rise in demand for
white meat in the North American and European countries is in turn expected to support
growth of the veterinary vaccines market in the near future. According to the PoultrySite Poultry News, Health, Welfare, Diseases, Markets and Economics, in 2013, there was a
significant rise in demand for white meat in Italy since a decade, with demand for turkey,
chicken and eggs increased by 8.5%, while production of poultry increased by 16%.
Market Taxonomy
This report segments the global veterinary vaccines market on the basis of technology, animal
type and geography. On the basis of product type, the market is categorized into inactivated
vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, subunit and DNA
vaccines. On the basis of animal type, the market is segmented into companion animal and
livestock animal. The companion animal type segment is sub-segmented into equine, canine,
and feline. The livestock animal type segment is further sub-segmented into bovine, ovine,
porcine, poultry and other animals. For comprehensive understanding of market dynamics, the
global veterinary vaccines market is analyzed across key geographical regions namely North
America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is
analyzed on basis of market findings across major countries in these regions for a macro-level
understanding of the market.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/veterinary-vaccines-market-125
Key companies covered as a part of this study include Zoetis Inc. Merck Animal Health, Merial
Inc. , Boehringer Ingelheim , Bayer Animal Health, Elanco Animal Health, Ceva Animal Health,
Heska Corporation, Virbac Inc., and Indian Immunological Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Veterinary/Animal vaccines are parenteral products that are used as prophylactic as well as in treatment of various veterinary diseases.